Saturday, September 19, 2026

AI

250 articles

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai AI Stock Rebounds: Is It Time to Buy Now?

C3.ai shares have rebounded 6% after a recent decline, sparking questions about whether it's an undervalued opportunity. With a year-to-date loss of 60.69%, investors are reassessing growth prospects. The stock's price-to-sales ratio of 5x is above industry averages, raising concerns about relative valuation.

Via News Editorial
Stock Market Rises Amid Hopes of Recovery, But AI-Driven Valuations Remain Concerning

Stock Market Rises Amid Hopes of Recovery, But AI-Driven Valuations Remain Concerning

US stock futures rose on a shortened Thanksgiving week, signaling potential recovery after a pullback amid concerns over AI-driven market rally valuations. The Dow, S&P 500, and Nasdaq all gained ground, but major indexes have lost notable ground in November as investors reassess high valuations in tech stocks.

Via News Editorial
AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI Stocks Set to Outperform Apple by 2026: Key Analysis

AI stocks Alphabet and Microsoft are poised to outperform Apple by year-end 2026, according to a detailed analysis. With faster growth and lower valuations, these stocks are expected to surpass Apple's market cap.

Via News Editorial
AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD vs. Intel: Which Chipmaker Is Poised for Explosive Data Center Growth?

AMD and Intel are at the forefront of data center competition as AI infrastructure continues to grow. AMD's MI300 and MI400 GPUs have seen significant success, while Intel's data center business has struggled. With $4.3 billion in revenue for AMD and $4.1 billion for Intel in the third quarter of 2025, AMD's full-stack approach could provide a strategic advantage over Intel.

Via News Editorial
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Boom Hits a Fork: Slowdown Calls Clash with Capex Confidence as Markets Get Nervous
Dario Amodei's repeated calls for a global slowdown in frontier AI development, echoed by Microsoft's new humanist AI code of conduct and FTC antitrust caution, are being publicly rejected by Nvidia and Meta leadership even as hyperscaler spending draws fresh skeptical scrutiny (Wachter's analysis, Burry-style overbuilding worries) and weak guidance from Adobe and a post-slowdown-comment selloff in GE Vernova signal investor jitters. Meanwhile wealth and security effects of the AI race keep compounding — Zhang Yiming's fortune surging on AI-driven ByteDance value, a Chinese hacking firm weaponizing AI against stolen government secrets, and low-quality AI-generated products (an AI sitcom, a spam-flooding agent platform) fueling backlash even as adoption races ahead.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Berkshire Hathaway
Both facts report Berkshire Hathaway's cash position on 2026-01-01 with identical observation timestamps, but claim vastly different values: 380 billion USD vs 400 USD. These cannot both be true for the same entity at the same point in time. The magnitude of the discrepancy (a factor of ~10^9) rules out rounding, unit conversion, or methodological differences.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,982
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,982 facts checked against source5,299 source documents archived
Query this data → isubstrate.com